Expertise in
9
conditions

Dr. Fayz A. Hudefi

Psychiatry
Western Arkansas Counseling And Guidance Center Inc
3111 S 70th St, 
Fort Smith, AR 
Accepting New Patients
Offers Telehealth
Expertise in
9
conditions
Western Arkansas Counseling And Guidance Center Inc
3111 S 70th St, 
Fort Smith, AR 

Overview

Fayz Hudefi is a Psychiatrist in Fort Smith, Arkansas. Dr. Hudefi is highly rated in 9 conditions, according to our data. His top areas of expertise are Alzheimer's Disease, Vascular Dementia, Schizoaffective Disorder, and Major Depression. Dr. Hudefi is currently accepting new patients.

His clinical research consists of participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Psychiatry

Licenses

Psychiatry & Neurology in AR

Hospital Affiliations

Mena Regional Health System

Languages Spoken

English
Arabic

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Arkansas Health and Wellness
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

HMO Partners
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
QualChoice
  • MEDICARE MAPD
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

WESTERN ARKANSAS COUNSELING AND GUIDANCE CENTER, INC
3111 S 70th St, Fort Smith, AR 72903

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 2a, Randomized, Double-blind, Placebo-controlled Proof of Concept Study to Evaluate the Effects of Oral BTRX-335140 (NMRA-335140) Versus Placebo in Subjects With Major Depressive Disorder
A Phase 2a, Randomized, Double-blind, Placebo-controlled Proof of Concept Study to Evaluate the Effects of Oral BTRX-335140 (NMRA-335140) Versus Placebo in Subjects With Major Depressive Disorder
Enrollment Status: Completed
Publish Date: May 29, 2025
Intervention Type: Drug
Study Drug: BTRX-335140
Study Phase: Phase 2
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200 in Treatment-Seeking Individuals With Methamphetamine Use Disorder
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200 in Treatment-Seeking Individuals With Methamphetamine Use Disorder
Enrollment Status: Terminated
Publish Date: October 04, 2024
Intervention Type: Drug, Other
Study Phase: Phase 2
BAT3221032: A Randomized, Controlled Study to Evaluate the Effects of Switching From Cigarette Smoking to Using One of Five Variants of a Heated Tobacco Product on Biomarkers of Exposure and Biomarkers of Potential Harm in Healthy Subjects
BAT3221032: A Randomized, Controlled Study to Evaluate the Effects of Switching From Cigarette Smoking to Using One of Five Variants of a Heated Tobacco Product on Biomarkers of Exposure and Biomarkers of Potential Harm in Healthy Subjects
Enrollment Status: Completed
Publish Date: December 16, 2022
Intervention Type: Other
Study Phase: Not Applicable
A Randomized, Double-Blind, Vehicle-Controlled, Parallel, Phase II Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia
A Randomized, Double-Blind, Vehicle-Controlled, Parallel, Phase II Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia
Enrollment Status: Completed
Publish Date: October 13, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of CX-8998 for Essential Tremor
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of CX-8998 for Essential Tremor
Enrollment Status: Completed
Publish Date: November 23, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Multi-Center, Open-Label, Parallel-Cohort Study to Characterize Product Use in Smokers Switching From Combustible Cigarettes to a RELX Electronic Nicotine Delivery System (ENDS)
A Randomized, Multi-Center, Open-Label, Parallel-Cohort Study to Characterize Product Use in Smokers Switching From Combustible Cigarettes to a RELX Electronic Nicotine Delivery System (ENDS)
Enrollment Status: Completed
Publish Date: July 22, 2021
Intervention Type: Other
Study Phase: Not Applicable
A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia
A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia
Enrollment Status: Terminated
Publish Date: December 03, 2019
Intervention Type: Drug
Study Phase: Phase 3
Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
Enrollment Status: Completed
Publish Date: October 24, 2018
Intervention Type: Drug
View 7 Less Clinical Trials
Similar Doctors
Expertise in
6
conditions
Dr. Rachel R. Fiori
Psychiatry
Expertise in
6
conditions
Dr. Rachel R. Fiori
Psychiatry

Center For Psychiatric Wellness, PLLC

7217 Cameron Park Dr, 
Fort Smith, AR 
 (0.2 miles away)
479-831-6007
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rachel Fiori is a Psychiatrist in Fort Smith, Arkansas. Dr. Fiori is highly rated in 6 conditions, according to our data. Her top areas of expertise are Seasonal Affective Disorder (SAD), Major Depression, Generalized Anxiety Disorder (GAD), and Obsessive-Compulsive Disorder (OCD). Dr. Fiori is currently accepting new patients.

Expertise in
6
conditions
Dr. William C. Kindrick
Psychiatry
Expertise in
6
conditions
Dr. William C. Kindrick
Psychiatry

Center For Psychiatric Wellness, PLLC

7217 Cameron Park Dr, 
Fort Smith, AR 
 (0.2 miles away)
479-831-6007
Languages Spoken:
English
See accepted insurances
Accepting New Patients

William Kindrick is a Psychiatrist in Fort Smith, Arkansas. Dr. Kindrick is highly rated in 6 conditions, according to our data. His top areas of expertise are Seasonal Affective Disorder (SAD), Major Depression, Bipolar Disorder (BPD), and Schizoaffective Disorder. Dr. Kindrick is currently accepting new patients.

Expertise in
6
conditions
Dr. Eric S. Broadway
Psychiatry
Expertise in
6
conditions
Dr. Eric S. Broadway
Psychiatry

Stigler Health And Wellness Center Inc

204 Wall St, Suite A, 
Poteau, OK 
 (25.8 miles away)
800-640-9741
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Eric Broadway is a Psychiatrist in Poteau, Oklahoma. Dr. Broadway is highly rated in 6 conditions, according to our data. His top areas of expertise are Schizoaffective Disorder, Bipolar Disorder (BPD), Major Depression, and Schizophrenia. Dr. Broadway is currently accepting new patients.

Frequently Asked Questions about Dr. Fayz A. Hudefi

How do I make an appointment with Dr. Fayz A. Hudefi?

You can book an appointment with Dr. Fayz A. Hudefi by calling their office at 479-452-6650. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Fayz A. Hudefi a top-rated expert for Alzheimer's Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Fayz A. Hudefi is classified as an Distinguished expert for Alzheimer's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Fayz A. Hudefi specialize in?

While Dr. Fayz A. Hudefi is a Psychiatry, they have specific expertise in Alzheimer's Disease, Vascular Dementia, and Schizoaffective Disorder. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Psychiatry.

Does Dr. Fayz A. Hudefi accept my insurance?

Dr. Fayz A. Hudefi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 479-452-6650 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hudefi's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile